Fennec looks for FDA approval for hearing loss drug haunted by manufacturing problems
Third time’s the charm. Maybe.
Fennec Pharmaceuticals announced this morning that the FDA is reviewing its NDA for its only candidate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
